Effects of different treatments for hyperthyroidism on the hypothalamic-pituitary-adrenal axis

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 9, 2008, Pages 1085-1090

  Lizcano, Fernando ^a   Salvador, Javier ^b  

^a UNIVERSIDAD DE LA SABANA   (Colombia)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Adrenocorticotrophin; Carbimazole; Cortisol; Hyperthyroidism; Hypothalamic pituitary adrenal axis; Iopanoic acid

Indexed keywords

ARGIPRESSIN; CARBIMAZOLE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE; IOPANOIC ACID; LIOTHYRONINE; NEOTOMIZOL; THYROID HORMONE; THYROTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; DRUG MECHANISM; GRAVES DISEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYDROCORTISONE URINE LEVEL; HYPERTHYROIDISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIOTHYRONINE BLOOD LEVEL; MALE; THYROTROPIN BLOOD LEVEL; TOXIC GOITER;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; ANTITHYROID AGENTS; CARBIMAZOLE; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; HYDROCORTISONE; HYPERTHYROIDISM; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IOPANOIC ACID; MIDDLE AGED; PITUITARY-ADRENAL FUNCTION TESTS; PITUITARY-ADRENAL SYSTEM; THYROTROPIN; YOUNG ADULT;

EID: 48749120628     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.04966.x     Document Type: Article

References (32)

1. Franklyn JA. The management of hyperthyroidism. N. Engl. J. Med. 1994 330 : 1731 8.
2. Allahabadia A, Daykin J, Holder RL, Sheppard MC, Gough SCL, Franklyn JA. Age and gender predict the outcome of treatment for Graves' hyperthyroidism. J. Clin. Endocrinol. Metab. 2000 85 : 1038 42.
3. Triveri MG, Oudit GY, Sah R et al. Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction. Proc. Natl Acad. Sci. USA 2006 103 : 6043 8.
4. Gallagher TF, Hellman L, Finkelstein J et al. Hyperthyroidism and cortisol secretion in man. J. Clin. Endocrinol. Metab. 1972 34 : 919 27.
5. Linquette M, Lefebvre J, Racadot A, Cappoen JP, Fontaine-Delort S. Production rate and mean plasma concentration of cortisol in hyperthyroidism. Ann. Endocrinol. 1976 37 : 331 5.
6. Sanchez-Franco F, Fernandez L, Fernandez G, Cacicedo L. Thyroid hormone action on ACTH secretion. Hormone Metab. Res. 1989 21 : 550 2.
7. Kamilaris TC, DeBold CR, Johnson EO et al. Effects of short and long duration hypothyroidism and hyperthyroidism on the plasma adrenocorticotropin and corticosterone responses to ovine corticotropin-releasing hormone in rats. Endocrinology 1991 128 : 2567 76.
8. Goswarmi R, Gupta N, Bal CS, Kochupillai N. Cortisol reserves and adrenal size in patients with Graves' disease. J. Assoc. Physicians India 1998 46 : 1008 11.
9. Gordon GG, Southren AL. Thyroid-hormone effects on steroid-hormone metabolism. Bull. N.Y. Acad. Med. 1977 53 : 241 59.
10. Tsatsoulis A, Johnson EO, Kalogera CH, Seferiadis K, Tsolas O. The effect of thyrotoxicosis on adrenocortical reserves. Eur. J. Endocrinol. 2000 142 : 233 5.
11. Bal CS, Kumar A, Chandra P. Effect of iopanoic acid on radioiodine therapy of hyperthyroidism: Long-term outcome of a randomized controlled trial. J. Clin. Endocrinol. Metab. 2005 90 : 6536 40.
12. Braga M, Cooper DS. Clinical review 129: Oral cholecystographic agents and the thyroid. J. Clin. Endocrinol. Metab. 2001 86 : 1853 60.
13. Panzer C, Beazley R, Braverman L. Rapid preoperative preparation for severe hyperthyroid Graves' disease. J. Clin. Endocrinol. Metab. 2004 89 : 2142 4.
14. Hall R, Besser GM. Fundamentals of Clinical Endocrinology, 5th edn. Edinburgh Churchill Livingstone, New York. 1989.
15. Llorente I, Lizcano F, Alvarez R et al. Cholinergic modulation of spontaneous hypothalamic-pituitary-adrenal activity and its circadian variation in man. J. Clin. Endocrinol. Metab. 1996 81 : 2902 7.
16. Moghetti P, Castello R, Tosi F. Glucose counterregulatory response to acute hypoglycemia in hyperthyroid human subjects. J. Clin. Endocrinol. Metab. 1994 78 : 169 73.
17. Johnson EO, Kamilaris TC, Calogero AE, Gold PW, Chrousos GP. Experimentally-induced hyperthyroidism is associated with activation of the rat hypothalamic-pituitary-adrenal axis. Eur. J. Endocrinol. 2005 153 : 177 85.
18. Taniyama M, Honma K, Ban Y. Urinary cortisol metabolites in the assessment of peripheral thyroid hormone action: Application for diagnosis of resistance to thyroid hormone. Thyroid 1993 3 : 229 33.
19. Doe RP, Fernandez R, Seal US. Measurement of corticosteroid binding globulin in man. J. Clin. Endocrinol. Metab. 1974 24 : 1029 39.
20. Berk RN, Loeb PM, Goldberger LE, Sokoloff J. Oral cholecystography with iopanoic acid. N. Engl. J. Med. 1974 24 : 204 10.
21. Wang YS, Tsou CT, Lin WH, Hershman JM. Long term treatment of Graves' disease with iopanoic acid (Telepaque). J. Clin. Endocrinol. Metab. 1987 65 : 679 83.
22. Kleinmann RE, Vagenakis AG, Braverman LE. The effect of iopanoic acid on the regulation of thyrotropin secretion in euthyroid subjects. J. Clin. Endocrinol. Metab. 1980 51 : 399 03.
23. Kamilaris TC, DeBold CR, Pavlou SN, Island DP, Hoursanidis A, Orth DN. Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function. J. Clin. Endocrinol. Metab. 1987 65 : 994 9.
24. 3 levels enhances, but does not normalize, the GH response to GHRP-6 plus GHRH in thyrotoxicosis. J. Endocrinol. Invest. 2003 26 : 733 7.
25. Redei E, Rittenhouse PA, Revskoy S, McGivern RF, Aird F. A novel endogenous corticotropin release inhibiting factor. Ann. N.Y. Acad. Sci. 1998 840 : 456 69.
26. Bianco AC, Kim BW. Deiodinases: Implications of the local control of thyroid hormone action. J. Clin. Invest. 2006 116 : 2571 9.
27. Sanchez VC, Goldstein J, Stuart RC et al. Regulation of hypothalamic prohormone convertases 1 and 2 and effects on processing of prothyrotropin- releasing hormone. J. Clin. Invest. 2004 114 : 357 69.
28. Araki O, Morimura T, Ogiwara T, Mizuma H, Mori M, Murakami M. Expression of type 2 iodothyronine deiodinase in corticotrpin-secreting mouse pituitary tumor cells is stimulated by glucocorticoid and corticotropin-releasing hormone. Endocrinology 2003 144 : 4459 65.
29. Bauer M, Heinz A, Whybrow PC. Thyroid hormones, serotonin and mood. Of synergy and significance in the adult brain. Mol. Psychiatry 2002 7 : 140 55.
30. Sandrini M, Vitale G, Vergoni AV, Ottani A, Bertolini A. Effect of acute and chronic treatment with triiodothyronine on serotonin levels and serotonergic receptor subtypes in the rat brain. Life Sci. 1996 58 : 1551 9.
31. Bernadini R, Chiarenza A, Kamilaris TC et al. In vivo and in vitro effects of arginine-vasopressin receptor antagonists on the hypothalamic- pituitary-adrenal axis in the rat. Neuroendocrinology 1994 60 : 503 8.
32. Ciosek J, Drobnik J. Vasopressin and oxytocin release and the thyroid function. J. Physiol. Pharmacol. 2004 55 : 423 41.